title: Molecular basis of alcoholic fatty liver disease: From incidence to treatment.
abstract: Alcoholic liver diseases have complex and multiple pathogenic mechanisms but still no effective treatment. Steatosis or alcoholic fatty liver disease (AFLD) has a widespread incidence and is the first step in the progression to more severe stages of alcoholic liver disease, with concomitant increases in morbidity and mortality rates. The ways in which this progression occurs and why some individuals are susceptible are still unanswered scientific questions. Research with animal models and clinical evidence have shown that it is a multifactorial disease that involves interactions between lipid metabolism, inflammation, the immune response and oxidative stress. Each of these pathways provides a better understanding of the pathogenesis of AFLD and contributes to the development of therapeutic strategies. This review emphasizes the importance of research on alcoholic steatosis based on incidence data, key pathogenic mechanisms and therapeutic interventions, and discusses perspectives on the progression of this disease.
authors.affiliation: Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.
authors.forename: Francislaine Ar
authors.initials: FA
authors.lastname: Lívero
authors.affiliation: Department of Pharmacology, Federal University of Paraná, Curitiba, Brazil.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Acco
keywords: alcohol; alcoholic fatty liver disease; ethanol; pathogenesis; steatosis; treatment